Skip to main content


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Full Schedule

Full Schedule

  • Monday, April 18, 2022
  • 1:00 PM – 2:15 PM ET
    CL-18-100 - Making Medications for Opioid Use Disorder Work in Primary Care: Playbooks, Resources, and Lessons Learned
  • 1:00 PM – 2:15 PM ET
    PO-18-100 - The Case for Harm Reduction
  • 1:00 PM – 2:15 PM ET
    PP-18-100 - One Choice for Health: A Data-Informed, Youth-Driven Prevention Message
  • 1:00 PM – 2:15 PM ET
    PS-18-100 - Good Call: The Orlando Police Overdose Investigative Unit
  • 1:00 PM – 2:15 PM ET
    ADV-18-100 - Addiction Workforce Gaps: Improving the Treatment Ecosystem
  • 1:00 PM – 2:15 PM ET
    TREAT-18-100 - Mindfulness-Oriented Recovery Enhancement: A New, Neuroscience-Based Treatment for Opioid Misuse, Opioid Use Disorder, and Chronic Pain
  • 1:00 PM – 2:15 PM ET
    TECH-18-100 - Expanding During Shutdown: Virtually Delivering Substance Use Disorder Services to Rural Communities
  • 1:00 PM – 2:15 PM ET
    TREND-18-100 - Opioid Settlement: Guidance to Community Policymakers
  • 1:00 PM – 2:15 PM ET
    ILL-18-100 - Methamphetamine Use in the United States: Epidemiological Update and Implications for Prevention, Treatment, and Harm Reduction
  • 2:15 PM – 2:30 PM ET
    Break
  • 2:30 PM – 3:45 PM ET
    CL-18-230 - Improving Care for Hospitalized Patients With Opioid Use Disorder
  • 2:30 PM – 3:45 PM ET
    PO-18-230 - Tribal Opioid Overdose Prevention Responses: COVID-19 and the Pivot to Telehealth
  • 2:30 PM – 3:45 PM ET
    PP-18-230 - Accelerating Upstream Together to Improve Outcomes for Families Affected by the Opioid Crisis
  • 2:30 PM – 3:45 PM ET
    PS-18-230 - Stigma, Law Enforcement, and the Justice System
  • 2:30 PM – 3:45 PM ET
    ADV-18-230 - Changing the Way Our Nation Addresses Addiction: Disrupting the Cycle of Stigma in Policy and Media
  • 2:30 PM – 3:45 PM ET
    TREAT-18-230 - Understanding and Assessing Rural Recovery Ecosystems
  • 2:30 PM – 3:45 PM ET
    TECH-18-230 - PDMP Interstate Data Sharing and Electronic Health Record Integration
  • 2:30 PM – 3:45 PM ET
    TREND-18-230 - Opioid Settlement: Protecting and Optimizing Proceeds
  • 2:30 PM – 3:45 PM ET
    ILL-18-230 - The Rise of Fentanyl: Saving Lives by Moving Communities From Understanding to Action
  • 3:45 PM – 4:00 PM ET
    Break
  • 4:00 PM – 5:30 PM ET
    Plenary Session
  • 5:30 PM – 7:00 PM ET
    Opening Reception in Exhibit Hall
  • Tuesday, April 19, 2022
  • 7:00 AM – 8:00 AM ET
    Open 12-Step Meeting
  • 8:00 AM – 8:45 AM ET
    Vision Sessions

    Vision Session

  • 8:45 AM – 9:00 AM ET
    Break
  • 9:00 AM – 11:00 AM ET
    Plenary Session
  • 11:00 AM – 11:15 AM ET
    Break
  • 11:00 AM – 2:00 PM ET
    Lunch in Exhibit Hall
  • 11:15 AM – 12:30 PM ET
    TECH-19-1115 - Data to Action: How ATLAS® and Quality Metrics Support Transformation of the Addiction Treatment System
  • 11:15 AM – 12:30 PM ET
    CL-19-1115 - Addiction Workforce Gaps: Combining Federal Resources and Academic Addiction Medicine to Promote Best Practices in Addiction Care
  • 11:15 AM – 12:30 PM ET
    ADV-19-1115 - A Movement to End Addiction Stigma: Background, Implementation, and 1-Year Outcomes of the Collaborative Life Unites Us Stigma Reduction Campaign Utilizing the Shatterproof Strategy
  • 11:15 AM – 12:30 PM ET
    ILL-19-1115 - Fentanyl Test Strips for Harm Reduction and Overdose Prevention: Research and Legislative Update
  • 11:15 AM – 12:30 PM ET
    PO-19-1115 - Innovative Approaches to Access Treatment and Harm Reduction Services in a Rural, Underserved Community
  • 12:30 PM – 12:45 PM ET
    Break
  • 12:45 PM – 2:00 PM ET
    TREAT-19-1245 - Stronger Together: Combining Medication for Opioid Use Disorders With 12-Step Recovery Support to Achieve Five-Year Recovery
  • 12:45 PM – 2:00 PM ET
    TECH-19-1245 - Data-Driven Transformation: Lessons from DEA Diversion, Intel, and Outreach
  • 12:45 PM – 2:00 PM ET
    TREND-19-1245 - Opioid Settlement: Assessing State’s Response Using Guiding Principles
  • 12:45 PM – 2:00 PM ET
    PP-19-1245 - Health Equity Needs Assessment to Advance Overdose Prevention Strategies
  • 12:45 PM – 2:00 PM ET
    PS-19-1245 - Integrative Justice: A Healthcare Approach to Treatment Courts
  • 2:00 PM – 2:15 PM ET
    Break
  • 2:15 PM – 3:30 PM ET
    CL-19-215 - Clinical Consideration for Working With the LGBTQIA2+ Population
  • 2:15 PM – 3:30 PM ET
    PO-19-215 - HEALing Communities Study: Deploying Evidence-Based Practices to Reduce Opioid Overdose Deaths Through Community Engagement and Partnerships
  • 2:15 PM – 3:30 PM ET
    PP-19-215 - GOODLIFE: Tier 1 and 2 Prevention and Intervention Educational Curriculum
  • 2:15 PM – 3:30 PM ET
    PS-19-215 - Reducing Overdose and Withdrawal-Related Deaths and Implementing Medication for Opioid Use Disorder Programs in Jails and Prisons
  • 2:15 PM – 3:30 PM ET
    ADV-19-215 - Hope in Eastern Kentucky: Lessons From Previous Decreases in Drug Overdose Deaths
  • 2:15 PM – 3:30 PM ET
    TREAT-19-215 - Creative Expression in Treatment and Recovery
  • 2:15 PM – 3:30 PM ET
    TECH-19-215 - Advancing Data to Action: Enhancing Public Health Surveillance and Action Through PDMP Data
  • 2:15 PM – 3:30 PM ET
    TREND-19-215 - Lessons From Oklahoma's Opioid Settlement: Providing Treatment, Advancing Research, and Distributing Free Buprenorphine
  • 2:15 PM – 3:30 PM ET
    ILL-19-215 - Examining Polydrug Use Among Adults Reporting Illicitly Manufactured Fentanyl Use, Heroin Use, or Prescription Opioid Misuse
  • 3:30 PM – 4:30 PM ET
    Break in Exhibit Hall
  • 4:30 PM – 5:45 PM ET
    CL-19-430 - Findings From Respond to Prevent: A Four-State Study to Improve Provision of Naloxone, Buprenorphine, and Nonprescription Syringes in Community Pharmacies
  • 4:30 PM – 5:45 PM ET
    PO-19-430 - Developing a Framework to Reduce Overdose and Deliver Positive Change for People Who Use Psychostimulants in Rural Environments During COVID-19
  • 4:30 PM – 5:45 PM ET
    PP-19-430 - Breaking the Generational Cycle of Drug Use: Substance Use Prevention for School-Aged Children
  • 4:30 PM – 5:45 PM ET
    PS-19-430 - Embedding Evidenced-Based Peer Specialist Services From the Inside Out
  • 4:30 PM – 5:45 PM ET
    ADV-19-430 - Neonatal Abstinence Syndrome: Substance Exposure Impacts on Development and Support for Children and Caregivers
  • 4:30 PM – 5:45 PM ET
    TREAT-19-430 - Establishing and Integrating Recovery Certified Congregations Into Community Recovery Oriented Systems of Care
  • 4:30 PM – 5:45 PM ET
    TECH-19-430 - Integrating Electronic Health Records With PDMPs
  • 4:30 PM – 5:45 PM ET
    TREND-19-430 - Lessons From Virginia's Opioid Settlement: Invest in Youth-Oriented Primary Prevention
  • 4:30 PM – 5:45 PM ET
    ILL-19-430 - The New Emergency Department Drug Surveillance Program: Understanding and Monitoring Local Opioid and Other Drug Trends
  • 5:45 PM – 6:00 PM ET
    Break
  • 6:00 PM – 7:00 PM ET
    Plenary Session
  • Wednesday, April 20, 2022
  • 7:00 AM – 8:00 AM ET
    Open 12-Step Meeting
  • 8:00 AM – 8:45 AM ET
    Vision Sessions

    Vision Session

  • 8:45 AM – 9:00 AM ET
    Break
  • 9:00 AM – 11:00 AM ET
    Plenary Session
  • 11:00 AM – 11:15 AM ET
    Break
  • 11:00 AM – 2:00 PM ET
    Lunch in Exhibit Hall
  • 11:15 AM – 12:30 PM ET
    TECH-20-1115 - Assessing Consumer-Facing Mobile Apps for Recovery Management for People With Opioid Use Disorder
  • 11:15 AM – 12:30 PM ET
    CL-20-1115 - Addiction Workforce Gaps: Using Project ECHO to Engage Rural Providers and Medical Students
  • 11:15 AM – 12:30 PM ET
    ADV-20-1115 - Reframing the Drug Epidemic as Commercialized Recreational Pharmacology
  • 11:15 AM – 12:30 PM ET
    ILL-20-1115 - Counterfeit Pills: What Every American Should Know
  • 11:15 AM – 12:30 PM ET
    PO-20-1115 - Post-Overdose Outreach Program in Massachusetts
  • 12:30 PM – 12:45 PM ET
    Break
  • 12:45 PM – 2:00 PM ET
    PO-20-1245-A412 - Harm Reduction Principles and Their Effective Application
  • 12:45 PM – 2:00 PM ET
    TREAT-20-1245 - Implementation and Evaluation of PEERhelp Rural Communities Opioid Response Program
  • 12:45 PM – 2:00 PM ET
    TECH-20-1245 - Identifying High-Risk Patients With PDMPs
  • 12:45 PM – 2:00 PM ET
    TREND-20-1245 - Expanding Rural Access to Medication Assisted Treatment During COVID-19 and Other Adverse Conditions
  • 12:45 PM – 2:00 PM ET
    PS-20-1245 - New Jersey’s Multi-Disciplinary Framework: Developing Forensic Intelligence and Creating a New Culture Linking Individuals With Substance Use Disorder to Appropriate Levels of Care
  • 2:00 PM – 2:15 PM ET
    Break
  • 2:15 PM – 3:30 PM ET
    PO-20-215-A411 - Statewide Quick Response Teams: Lessons From Ohio and West Virginia
  • 2:15 PM – 3:30 PM ET
    PO-20-215-A412 - Naloxone Initiatives and Syringe Service Programs in the Veterans Health Administration: Critical Lessons During the Fourth Wave
  • 2:15 PM – 3:30 PM ET
    CL-20-215 - Increasing Buprenorphine Access in Rural North Carolina via Innovative Pharmacy-Focused Solutions
  • 2:15 PM – 3:30 PM ET
    PS-20-215 - Role of Medicaid and Department of Corrections: Pre-Release and Substance Use Disorder Care
  • 2:15 PM – 3:30 PM ET
    ADV-20-215 - Children Affected by Substance Abuse: A Multidisciplinary Approach to Serving the Epidemic’s Most Vulnerable Victims
  • 2:15 PM – 3:30 PM ET
    TREAT-20-215 - Bringing Alternative Services to Rural Communities
  • 2:15 PM – 3:30 PM ET
    TECH-20-215 - Out of the Box: New Methods to Identify Emerging Drug Threats
  • 2:15 PM – 3:30 PM ET
    TREND-20-215 - Engaging Employers to Support Employees in Treatment and Hire People in Recovery
  • 2:15 PM – 3:30 PM ET
    ILL-20-215 - CReDO: Community Response to Drug Overdoses
  • 3:30 PM – 4:30 PM ET
    Break in Exhibit Hall
  • 4:30 PM – 5:45 PM ET
    PO-20-430-A411 - Public Health and Public Safety Partnerships for Overdose Prevention and Response
  • 4:30 PM – 5:45 PM ET
    PO-20-430-A412 - Medical Examiners: Supporting Overdose Prevention and Training for Overdose Investigations and Mortality Data
  • 4:30 PM – 5:45 PM ET
    CL-20-430 - Naloxone for Risk Management in Primary Care, Pharmacy, Families, and Beyond
  • 4:30 PM – 5:45 PM ET
    PS-20-430 - State Efforts to Improve Outcomes for Justice-Involved Individuals With Opioid Use Disorder in Correctional Facilities and on Community Supervision
  • 4:30 PM – 5:45 PM ET
    ADV-20-430 - Project Hope: Supporting the Path to Recovery Through Partnerships
  • 4:30 PM – 5:45 PM ET
    TREAT-20-430 - Tennessee Recovery Navigators: Connecting Patients to Treatment From Hospital Emergency Departments
  • 4:30 PM – 5:45 PM ET
    TECH-20-430 - Using Geospatial Data to Identify Gaps in Substance Use Disorder Treatment
  • 4:30 PM – 5:45 PM ET
    TREND-20-430 - The New Age of Telehealth: What Is Working
  • 4:30 PM – 5:45 PM ET
    ILL-20-430 - Insights From State Data Into Deaths Related to Fentanyl, Fentanyl Analogs, Psychostimulants, and Novel Psychoactive Substances
  • 5:45 PM – 6:00 PM ET
    Break
  • 6:00 PM – 7:00 PM ET
    Plenary Session
  • Thursday, April 21, 2022
  • 7:00 AM – 8:00 AM ET
    Open 12-Step Meeting
  • 8:15 AM – 9:30 AM ET
    Breaking Down Silos: Leveraging the Power of Federal Cross-Sector Collaboration in the Overdose Epidemic
  • 9:30 AM – 9:45 AM ET
    Break
  • 9:45 AM – 11:00 AM ET
    CL-21-945 - Pain Management: Lessons From Michigan and West Virginia
  • 9:45 AM – 11:00 AM ET
    PP-21-945 - Using a Targeted Media Campaign to Prevent Opioid Misuse
  • 9:45 AM – 11:00 AM ET
    PS-21-945 - Community Paramedic and Healthcare Partnerships to Increase Engagement With Medication Assisted Treatment
  • 9:45 AM – 11:00 AM ET
    ADV-21-945 - Collegiate Recovery Communities: Presidents, Professors, and Peers
  • 9:45 AM – 11:00 AM ET
    TREAT-21-945 - State Efforts to Improve the Continuum of Care for Substance and Opioid Use Disorders
  • 9:45 AM – 11:00 AM ET
    ILL-21-945 - Urban-Rural and Geographic Differences in Drug Overdose Deaths
  • 9:45 AM – 4:00 PM ET
    SAM Summit

    SAM Summit

  • 11:00 AM – 11:15 AM ET
    Break
  • 11:15 AM – 12:30 PM ET
    PP-21-115 - Payer Panel: Strategic Initiatives Including Prevention, Treatment, and Recovery to Address Increased Opioid Overdose Rates During COVID-19
  • 11:15 AM – 12:30 PM ET
    TREAT-21-1115 - Medications for Opioid Use Disorder in Real-World Practice: Outcomes From a Longitudinal Study of Individuals With Opioid Use Disorder
  • 11:15 AM – 12:30 PM ET
    CL-21-1115 - Policy, Prescribing, and Clinical Practice: Lessons From Recent Evaluations in Kentucky
  • 11:15 AM – 12:30 PM ET
    ADV-21-1115 - Tennessee Hope Dealers: Building and Sustaining Recovery-Friendly Communities Through Evidence-Based Partnerships and Faith-Based Collaborations
  • 11:15 AM – 12:30 PM ET
    ILL-21-1115 - Skills and Strategies for the Treatment of Individuals With Stimulant Use Disorder
  • 11:15 AM – 12:30 PM ET
    TREND-21-1115 - Impact of Borders on Drug Trafficking
  • 11:15 AM – 12:30 PM ET
    PO-21-1115 - Syringe Service Programs Experience With Low-Threshold Buprenorphine Initiation
  • 11:15 AM – 12:30 PM ET
    PS-21-1115 - Innovative Strategies for Implementation of Alternative Response: Addressing 911 Behavioral Health Calls Without Law Enforcement